Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23388974 | 0.90 | TSHR (0.30) | TSHR | |
| SCHEMBL23388996 | 0.89 | — | — | |
| SCHEMBL23389006 | 0.87 | — | — | |
| SCHEMBL23388979 | 0.87 | — | — | |
| SCHEMBL23388958 | 0.79 | — | — | |
| SCHEMBL25251827 | 0.72 | TSHR (0.39) | TSHR | |
| SCHEMBL17935656 | 0.72 | TSHR (0.52) | TSHR | |
| SCHEMBL23388999 | 0.67 | TSHR (0.33) | TSHR | |
| SCHEMBL23389012 | 0.65 | TSHR (0.32) | TSHR | |
| SCHEMBL16257477 | 0.64 | TSHR (0.50) | TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250333375-A1 | CYANOCARBON COMPOSITIONS | ASCEND PERFORMANCE MATERIALS OPERATIONS LLC (US) | 2025-10-30 | — | — | US | disclosed |
| US-12215070-B2 | Cyanocarbon compositions | ASCEND PERFORMANCE MATERIALS OPERATIONS LLC (US) | 2025-02-04 | — | — | US | disclosed |
| EP-4061795-A1 | COMPOSITIONS COMPRISING TRISCYANOHEXANE | Ascend Performance Materials Operations LLC (US) | 2022-09-28 | — | — | EP | disclosed |
| CN-114555554-A | Composition comprising hexanetricarbonitrile | 奥升德功能材料运营有限公司 | 2022-05-27 | — | — | CN | disclosed |
| WO-2021102286-A1 | COMPOSITIONS COMPRISING TRISCYANOHEXANE | ASCEND PERFORMANCE MATERIALS OPERATIONS LLC (US) | 2021-05-27 | — | — | WO | disclosed |
| US-20210155579-A1 | CYANOCARBON COMPOSITIONS | ASCEND PERFORMANCE MATERIALS OPERATIONS LLC (US) | 2021-05-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12215070-B2 | Cyanocarbon compositions | CYCS, CBR3, PCCA | TSHR 4133/4885 |
| US-20250333375-A1 | CYANOCARBON COMPOSITIONS | CYCS, CBR3, PCCA | TSHR 4133/4885 |
| US-20210155579-A1 | CYANOCARBON COMPOSITIONS | CYCS, CBR3, PCCA | TSHR 4133/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.